1. Home
  2. XBIT vs SENS Comparison

XBIT vs SENS Comparison

Compare XBIT & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XBIT
  • SENS
  • Stock Information
  • Founded
  • XBIT 2005
  • SENS 1996
  • Country
  • XBIT United States
  • SENS United States
  • Employees
  • XBIT N/A
  • SENS N/A
  • Industry
  • XBIT Pharmaceuticals and Biotechnology
  • SENS Industrial Machinery/Components
  • Sector
  • XBIT Health Care
  • SENS Industrials
  • Exchange
  • XBIT Nasdaq
  • SENS Nasdaq
  • Market Cap
  • XBIT 194.5M
  • SENS 619.1M
  • IPO Year
  • XBIT 2015
  • SENS N/A
  • Fundamental
  • Price
  • XBIT $3.25
  • SENS $0.94
  • Analyst Decision
  • XBIT
  • SENS Strong Buy
  • Analyst Count
  • XBIT 0
  • SENS 1
  • Target Price
  • XBIT N/A
  • SENS $2.00
  • AVG Volume (30 Days)
  • XBIT 52.0K
  • SENS 20.3M
  • Earning Date
  • XBIT 03-14-2025
  • SENS 02-27-2025
  • Dividend Yield
  • XBIT N/A
  • SENS N/A
  • EPS Growth
  • XBIT N/A
  • SENS N/A
  • EPS
  • XBIT N/A
  • SENS N/A
  • Revenue
  • XBIT N/A
  • SENS $22,205,000.00
  • Revenue This Year
  • XBIT N/A
  • SENS $0.43
  • Revenue Next Year
  • XBIT N/A
  • SENS $60.55
  • P/E Ratio
  • XBIT N/A
  • SENS N/A
  • Revenue Growth
  • XBIT N/A
  • SENS 11.41
  • 52 Week Low
  • XBIT $3.25
  • SENS $0.25
  • 52 Week High
  • XBIT $9.96
  • SENS $1.20
  • Technical
  • Relative Strength Index (RSI)
  • XBIT 26.88
  • SENS 57.92
  • Support Level
  • XBIT $3.40
  • SENS $0.79
  • Resistance Level
  • XBIT $3.69
  • SENS $1.20
  • Average True Range (ATR)
  • XBIT 0.20
  • SENS 0.13
  • MACD
  • XBIT 0.05
  • SENS -0.01
  • Stochastic Oscillator
  • XBIT 3.85
  • SENS 50.08

About XBIT XBiotech Inc.

XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.

About SENS Senseonics Holdings Inc.

Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.

Share on Social Networks: